motherlodetv.net
Anthony Durkacz has a unique perspective on Canada’s emerging cannabis industry. Through his First Republic Capital, he has financed FSD Pharma (C.HUGE), Canntab Therapeutics (C.PILL), Cannara Biotech (C.LOVE) and, now, World-Class Extractions (C.PUMP). In each case Durkacz has been looking for business models which go well beyond the simple cultivation of cannabis.
I have an article up about FSD Pharma (C.HUGE) getting its medical sales licence up at Seeking Alpha.
Currently, we operate under a letter agreement that establishes a working relationship. This gives us the ability to do longer-term planning for the concentrate we produce. We work very closely with Mineral Solutions and provide them with the material they need to optimize and expand their process. Very much a win/win
FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), announced today that its wholly-owned subsidiary FV Pharma Inc. has received its Sale for Medical Purposes license to sell cannabis under the Cannabis Act (Canada). The license went into effect on April 18, 2019.